NVST — Envista Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual income statement for Envista Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,285	1,929	2,509	2,569	2,567
Cost of Revenue
Gross Profit	1,352	1,073	1,473	1,488	1,451
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	2,049	1,886	2,203	2,250	2,535
Operating Profit	236	43.5	306	319	31.5
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	234	-20	255	284	-54.9
Provision for Income Taxes
Net Income After Taxes	184	42.5	264	238	-100
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	218	33.3	341	243	-100
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	218	33.3	341	243	-100
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.41	0.699	1.83	1.54	0.542